Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03247309
Title TCR-engineered T Cells in Solid Tumors With Emphasis on NSCLC and HNSCC (ACTengine) (ACTengine)
Acronym ACTengine
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Immatics US, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | DEU

Facility Status City State Zip Country Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Universitätsklinikum Bonn, Venusberg-Campus 1 Bonn North Rhine-Westphalia 53127 Germany Details
Universitätsklinikum Carl Gustav Carus, Fetscherstr. 74 Dresden Saxony 01307 Germany Details
Universitätsklinikum Hamburg-Eppendorf Hamburg 20246 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field